Tokyo, Japan

Toru Hosokami

This inventor holds 2 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1991-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toru Hosokami. Retrieved from https://idiyas.com/inventor/toru-hosokami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Toru Hosokami

Introduction

Toru Hosokami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 2 patents, his work continues to influence the industry.

Latest Patents

Among his latest patents are Pyrrolo(2,1-B)thiazole derivatives, which are represented by a specific formula where R₁ can be a hydrogen atom, an alkyl group, or a cyclic alkyl group. Another notable patent is for Aminobenzamide derivatives, characterized by a formula where R₁ and R₂ each represent a lower alkoxy group. These compounds showcase his expertise in developing new chemical entities.

Career Highlights

Toru Hosokami is associated with Daiichi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical sector. His work at this organization has allowed him to focus on innovative drug development and contribute to advancements in medical science.

Collaborations

He has collaborated with notable coworkers such as Tosaku Miki and Masahide Asano, further enhancing the scope of his research and development efforts.

Conclusion

Toru Hosokami's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…